Harvard Apparatus Regenerative Technology, Inc. (HRGN) Operating cash flow 2016–2025
Harvard Apparatus Regenerative Technology, Inc. (HRGN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$3.8MFY2025 · since FY2016: -$9.1M → -$3.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.8M | +21.1% |
| FY2024 | -$4.9M | +30.1% |
| FY2023 | -$6.9M | -35.9% |
| FY2022 | -$5.1M | -94.3% |
| FY2021 | -$2.6M | +35.0% |
| FY2020 | -$4.0M | +33.3% |
| FY2019 | -$6.1M | +20.7% |
| FY2018 | -$7.6M | +30.7% |
| FY2017 | -$11.0M | -21.6% |
| FY2016 | -$9.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice